[203Pb]Pb-PSMA-CA012 presented with optimal uptake, and a first-in-human dosimetry study was subsequently performed using [203Pb]Pb-PSMA-CA012 in two prostate cancer patients. Here, FOLH1 is linked to prostate cancer.